Samsung Acquires NeuroLogica
- Samsung plans expansion into the medical device sector
- Computer giant acquires NeuroLogica as part of its expansion
Samsung has announced its acquisition of medical imaging company NeuroLogica. The technology giant plans to build a leading medical technology business and “the acquisition of NeuroLogica is another important step in the expansion of Samsung’s medical imaging business,” said Tod Pike, Senior VP at Samsung’s Enterprise Division.
The press statement outlines Samsung’s plans to expand its medical division, however terms of the deal itself were not disclosed.
NeuroLogica was founded in 2004 in Boston and it known for its portable computed tomography (CT) scanners, including BodyTom and CereTom.
Samsung has outlined ambitious plans to become one of the world’s leading medical equipment suppliers by 2020.
In November 2012, Samsung Electronics America, a subsidiary of Samsung, announced the addition of Samsung Health & Medical Equipment, which merged employees from Samsung Medison America, its ultrasound machine manufacturer, into its Enterprise Business Division.
Samsung had acquired Medison in 2010 and its medical technology business as a “key element in Samsung’s 2020 vision to explore new areas of growth,” said the company at the time.
- Samsung’s New Health Software Development Kit SuiteDigital Healthcare
- Intelerad acquires LUMEDX, expands cardiovascular expertiseTechnology & AI
- R&Q buyout forms largest regulatory firm for medical devicesMedical Devices & Pharma
- Samsung: Scaling Mobile Application with Amazon EKSTechnology & AI